Quadrant Capital Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.32M Buy
17,975
+1,224
+7% +$436K 0.19% 75
2025
Q4
$5.48M Buy
16,751
+1,927
+13% +$611K 0.17% 85
2025
Q3
$4.18M Sell
14,824
-309
-2% -$89.6K 0.14% 105
2025
Q2
$4.23M Buy
15,133
+1,569
+12% +$444K 0.15% 100
2025
Q1
$4.23M Buy
13,564
+6,412
+90% +$1.89M 0.16% 76
2024
Q4
$1.86M Sell
7,152
-861
-11% -$255K 0.13% 101
2024
Q3
$2.58M Buy
8,013
+8
+0.1% +$2.62K 0.18% 68
2024
Q2
$2.5M Buy
8,005
+546
+7% +$160K 0.19% 69
2024
Q1
$2.12M Sell
7,459
-761
-9% -$223K 0.17% 83
2023
Q4
$2.37M Buy
8,220
+809
+11% +$220K 0.2% 71
2023
Q3
$1.99M Buy
7,411
+1,363
+23% +$340K 0.2% 69
2023
Q2
$1.34M Sell
6,048
-1,265
-17% -$294K 0.13% 107
2023
Q1
$1.77M Buy
7,313
+761
+12% +$187K 0.18% 77
2022
Q4
$1.72M Buy
6,552
+439
+7% +$118K 0.2% 75
2022
Q3
$1.38M Buy
6,113
+198
+3% +$48K 0.18% 83
2022
Q2
$1.44M Buy
5,915
+196
+3% +$48K 0.19% 79
2022
Q1
$1.38M Buy
5,719
+579
+11% +$133K 0.17% 85
2021
Q4
$1.16M Sell
5,140
-1,428
-22% -$301K 0.14% 108
2021
Q3
$1.4M Buy
6,568
+931
+17% +$214K 0.19% 81
2021
Q2
$1.37M Buy
5,637
+181
+3% +$44.5K 0.2% 80
2021
Q1
$1.36M Buy
5,456
+718
+15% +$171K 0.22% 72
2020
Q4
$1.09M Sell
4,738
-45
-0.9% -$10.4K 0.2% 80
2020
Q3
$1.22M Sell
4,783
-1,267
-21% -$314K 0.27% 64
2020
Q2
$1.43M Sell
6,050
-3,032
-33% -$692K 0.32% 57
2020
Q1
$1.84M Buy
9,082
+2,396
+36% +$523K 0.31% 58
2019
Q4
$1.58M Buy
6,686
+883
+15% +$195K 0.19% 87
2019
Q3
$1.1M Buy
5,803
+1,428
+33% +$274K 0.17% 98
2019
Q2
$784K Sell
4,375
-637
-13% -$114K 0.12% 133
2019
Q1
$928K Buy
5,012
+1,054
+27% +$201K 0.16% 99
2018
Q4
$749K Buy
3,958
+85
+2% +$16.6K 0.2% 85
2018
Q3
$784K Hold
3,873
0.22% 76
2018
Q2
$692K Buy
3,873
+10
+0.3% +$1.77K 0.24% 78
2018
Q1
$639K Buy
3,863
+109
+3% +$20K 0.23% 82
2017
Q4
$640K Sell
3,754
-26
-0.7% -$4.6K 0.26% 80
2017
Q3
$691K Buy
3,780
+107
+3% +$19K 0.29% 72
2017
Q2
$576K Buy
3,673
+214
+6% +$34.8K 0.25% 75
2017
Q1
$558K Buy
3,459
+64
+2% +$10.6K 0.25% 83
2016
Q4
$487K Buy
3,395
+792
+30% +$119K 0.24% 75
2016
Q3
$424K Buy
2,603
+119
+5% +$20.1K 0.28% 66
2016
Q2
$368K Sell
2,484
-69
-3% -$10.7K 0.25% 73
2016
Q1
$375K Buy
2,553
+169
+7% +$25.1K 0.24% 72
2015
Q4
$378K Sell
2,384
-315
-12% -$49.5K 0.26% 79
2015
Q3
$364K Sell
2,699
-34
-1% -$5.36K 0.25% 74
2015
Q2
$413K Buy
+2,733
New +$438K 0.26% 73

Other funds holding AMGN

Quadrant Capital Group's AMGN Position: Q1 2026 in Review

Quadrant Capital Group increased its Amgen (AMGN) stake by 7.3% in Q1 2026, buying an estimated $436K and bringing the position to 17,975 shares worth $6.32M. The position accounts for 0.19% of the portfolio, ranked #75.

Quadrant Capital Group first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Quadrant Capital Group held 17,975 shares of Amgen worth $6.32M as of Q1 2026.
  • Quadrant Capital Group bought 1,224 Amgen shares in Q1 2026, an estimated $436K.
  • Amgen made up 0.19% of Quadrant Capital Group's portfolio in Q1 2026, its #75 holding.
  • Quadrant Capital Group first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.